Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Nitroglycerin measurement |
Component |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate adverse reaction |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oral glyceryl trinitrate adverse reaction |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Modified release glyceryl trinitrate adverse reaction (disorder) |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Parenteral glyceryl trinitrate adverse reaction |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Transdermal glyceryl trinitrate adverse reaction |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate spray adverse reaction |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to nitroglycerin |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral glyceryl trinitrate allergy |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Modified release GTN allergy (disorder) |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Parenteral glyceryl trinitrate allergy |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Transdermal glyceryl trinitrate allergy |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate spray allergy |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate overdose |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning by nitroglycerin |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate-containing product in rectal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glyceryl trinitrate 2 milligram/1 gram conventional release rectal ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate [generic additions] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 5mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 300 microgram sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 500 microgram sublingual tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 600 microgram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 15mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 400micrograms CFC-free spray (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 2mg m/r buccal tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 3mg m/r buccal tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 5mg m/r buccal tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 2.6mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 6.4mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 10mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 1mg/mL injection solution 10mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 50mg/50mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 1mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 20 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 5mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 10mg/24hours transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glyceryl trinitrate in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate-containing product in transdermal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Modified release GTN (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 2 milligram/1 each prolonged-release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 2.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 6.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 9 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 25mg/amp injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 50mg/amp |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 1 milligram/1 each prolonged-release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 3 milligram/1 each prolonged-release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 5 mg prolonged-release buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.3mg tablet (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 400 microgram/1 each conventional release sublingual tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.6mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 2.5mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.2mg/hr disc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.3mg/hr disc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.4mg/hr disc |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 5mg/mL injection solution 5mL ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 400 microgram/hour prolonged-release transdermal patch |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 400mcg/spray spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 5mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.6mg/hr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.1mg/hr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.2mg/hr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerin 0.4mg/hr |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glyceryl trinitrate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Nitroglycerine 5mg/mL injection solution 200mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerine 5mg/mL injection solution 400mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerine 5mg/mL injection solution 20mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerine 5mg/mL injection solution 100mL bottle |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerine 5mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nitroglycerine 5mg/mL injection solution 10mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Transdermal nitroglycerin |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 0.4% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Administration of prophylactic glyceryl trinitrate |
Direct substance |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing glyceryl trinitrate in sublingual dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely glyceryl trinitrate 400 microgram/1 actuation conventional release sublingual spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 50mg/10mL solution for injection ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing glyceryl trinitrate in oropharyngeal dosage form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Administration of prophylactic glyceryl trinitrate |
Direct substance |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Parenteral glyceryl trinitrate allergy |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to nitroglycerin |
Causative agent (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oral glyceryl trinitrate allergy |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Modified release GTN allergy (disorder) |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate spray allergy |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Transdermal glyceryl trinitrate allergy |
Causative agent (attribute) |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
1,2-dinitroglycerin (substance) |
Is a |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glyceryl trinitrate 2.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate 2.5 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate 6.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate 6.5 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate 9 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate 9 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Glyceryl trinitrate 2 mg buccal tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Glyceryl trinitrate |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|